Patent · US Active

Compound based on cyanine scaffold for diagnosis sepsis by selectively detect glutathione

US9951226B2 · kind B2 · utility

0Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2015
Grant dateApr 24, 2018
Priority date
Expiry dateMay 13, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a compound based on cyanine scaffold for diagnosing sepsis by selectively detecting glutathione. The compound based on cyanine scaffold according to the present invention has the advantages of maintaining its structure in intracellular environment and of reacting selectively to glutathione only among many amino acids containing thiol group (R—SH) such as cysteine, homocysteine, and glutathione, to produce changes in absorption or fluorescence spectrum, making the compound useful for the detection of in vivo glutathione in biosamples and also for the diagnosis of sepsis characteristically displaying the changes of glutathione concentration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.